Core Laboratories' declining ROCE trend signals a mature business possibly facing new competition or smaller margins. Unless metrics shift positively, consider other investment opportunities.
Analysts are more negative on Core Laboratories after recent results, leading to a minor EPS downgrade for next year. Despite this, the unchanged consensus price target suggests lower forecast earnings won't affect the stock price. However, the company's revenue growth is expected to lag the industry average.
Despite Core Laboratories' move to profitability, the ongoing drop in revenue and share price indicates negative market sentiment. Investors are urged to consider other factors before investing.
Investors project strong growth for Core Laboratories given the high P/E ratio, showing confidence in the company's future earnings. Other investment risks should also be considered while investing, not just the P/E ratio.
$HP Inc (HPQ.US)$initiated at neutral by Citigroup, announced target price at $32.00. $Apple (AAPL.US)$initiated at buy by DA Citigroup, announced targe price at $60.00. $NVIDIA (NVDA.US)$was upgraded by Daiwa Capital from neutral to outperform, increased target price from $408.00 to $475.00. $Carnival (CCL.US)$was upgraded by Jefferies from hold to buy, increased target price from $9.00 to $25.00. $Ero Copper (ERO.US)$was d...
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Core Laboratories Stock Forum
$Apple (AAPL.US)$ initiated at buy by DA Citigroup, announced targe price at $60.00.
$NVIDIA (NVDA.US)$ was upgraded by Daiwa Capital from neutral to outperform, increased target price from $408.00 to $475.00.
$Carnival (CCL.US)$ was upgraded by Jefferies from hold to buy, increased target price from $9.00 to $25.00.
$Ero Copper (ERO.US)$ was d...
In reaction to earnings/guidance:
$Sunnova Energy International (NOVA.US)$ +13.6%, $Impinj (PI.US)$ +12%, $Etsy Inc (ETSY.US)$ +8.1%, $argenx SE (ARGX.US)$ +8.1%, $Netgear (NTGR.US)$ +6.9%, $Ford Motor (F.US)$ +6.7%(also increases dividend), $Myovant Sciences (MYOV.US)$ +6%, $Merit Medical Systems (MMSI.US)$ +6%, $Agnico Eagle (AEM.US)$ +5.8%, $Flex Ltd (FLEX.US)$ +5.1%, $Mid-America Apartment Communities Inc (MAA.US)$ +5%, $Plexus (PLXS.US)$ +5%, $Harley-Davidson (HOG.US)$ +5%, ...
• $Biogen (BIIB.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $265
• $Comerica (CMA.US)$ : Baird Upgrades to Neutral from Underperform - PT $85 (from $78)
• $Delta Air Lines (DAL.US)$ : UBS Upgrades to Buy from Neutral - PT $53 (from $44)
• $H.B. Fuller (FUL.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $85 (from $72)
• $Gap Inc (GPS.US)$ : Morgan Stanley Upgrades to EqualWeight from Underweight - PT $14
• $Zions Bancorp (ZION.US)$ : Baird U...
No comment yet